InsidersTradesSigma
Follow the Fulcrum Therapeutics, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Fulcrum Therapeutics, Inc. has logged 42 public disclosures. Market capitalisation: €243.2m. The latest transaction was reported on 20 July 2026 (Acquisition). Among the most active insiders: Gould Robert J. The full history is accessible without an account.
42
Insider Decl.
n/a
Thresholds
€31m
16 ops.
Buy Volume
€17m
12 ops.
Sell Volume
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 July 2026
Declarations42 total
116,671 shares@ US$3.560.17% mcap27.9% of flowCommon StockSEC:0001178579-26-000016:0
Canonical exit: 14 Oct 2026 (T+90)
50,945 shares@ US$3.520.074% mcap12.1% of flowCommon StockSEC:0001178579-26-000016:1
Canonical exit: 15 Oct 2026 (T+90)
75,952 shares@ US$3.580.11% mcap30.6% of flowCommon StockSEC:0001178579-26-000014:2
Canonical exit: 12 Oct 2026 (T+90)
12,966 shares@ US$3.540.019% mcap5.2% of flowCommon StockSEC:0001178579-26-000014:0
Canonical exit: 11 Oct 2026 (T+90)
53,651 shares@ US$3.560.080% mcap21.5% of flowCommon StockSEC:0001178579-26-000014:1
Canonical exit: 12 Oct 2026 (T+90)
107,377 shares@ US$3.560.16% mcap42.8% of flowCommon StockSEC:0001178579-26-000014:3
Canonical exit: 13 Oct 2026 (T+90)
18,000 sharesCommon StockSEC:0001193125-26-290622:0
15,000 shares@ US$10.87260.031% mcap7.8% of flowCommon StockSEC:0001193125-26-037606:0
15,000 shares@ US$10.72380.030% mcap7.6% of flowCommon StockSEC:0001193125-26-037573:0
15,000 shares@ US$11.87260.034% mcap8.5% of flowCommon StockSEC:0001193125-26-004572:0
3,452 shares@ US$12.9282.2% of flowCommon StockSEC:0001193125-25-322740:0
1,377,020 shares@ US$13.3335.5% of flowCommon StockSEC:0001231919-25-000596:0
15,000 shares@ US$11.0339.0% of flowCommon StockSEC:0001193125-25-291392:0
498 shares@ US$5.064.0% of flowCommon StockSEC:0000950170-25-068038:0
8,500,000 sharesCommon StockSEC:0001415889-24-022127:0
150,000 shares@ US$3.2750.0% of flowCommon StockSEC:0000950170-24-081949:0
236 shares@ US$7.763.0% of flowCommon StockSEC:0000950170-24-056947:0
4,884 shares@ US$11.715591.9% of flowCommon StockSEC:0000950170-24-028827:0
43,360 shares@ US$11.347550.0% of flowCommon StockSEC:0000950170-24-025933:0
Canonical exit: 2 Jun 2024 (T+90)
210 shares@ US$3.311.1% of flowCommon StockSEC:0000950170-23-021245:0
1,923,076 shares@ US$13.0080.4% of flowCommon StockSEC:0001104659-23-006213:0
Canonical exit: 20 Apr 2023 (T+90)
6,766 shares@ US$15.005.0% of flowCommon StockSEC:0000899243-23-001803:0
122,334 shares@ US$7.02762.8% of flowCommon StockSEC:0001104659-23-001881:0
Canonical exit: 4 Apr 2023 (T+90)
4,089 shares@ US$5.99410.1% of flowCommon StockSEC:0001104659-22-130982:0
Canonical exit: 27 Mar 2023 (T+90)
98,787 shares@ US$5.89971.9% of flowCommon StockSEC:0001104659-22-129121:0
Canonical exit: 19 Mar 2023 (T+90)
25 of 42 declarations
About Fulcrum Therapeutics, Inc.
Geographically, Fulcrum’s operating footprint is concentrated in the Boston/Cambridge biotech cluster, where it maintains its headquarters and laboratory space. That location provides access to talent, academic networks, and the broader U.S. life sciences ecosystem, but the company remains primarily a research and development organization with limited commercial infrastructure. Recent highlights include positive updates from the Phase 1b PIONEER study of pociredir in SCD, plans to advance toward a potential registration-enabling trial in the second half of 2026, and a stronger cash position at the end of 2025 following a public equity offering. Overall, Fulcrum remains a high-risk, high-upside rare-disease biotech listed on the NASDAQ Global Market in the United States.
